Question follow-through · 19703

Brain Cancer: Research

To ask the Secretary of State for Health and Social Care, to provide details of the distribution so far of funding from the December 2025 announcement from the National Institute for Health and Care Research of £13.7 million for brain tumour research, inc

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
16 Jul 2026
Target answer date
2 Sept 2026
Answer
7 Sept 2026 · 53 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 16 Jul 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, to provide details of the distribution so far of funding from the December 2025 announcement from the National Institute for Health and Care Research of £13.7 million for brain tumour research, inc

  2. 2 Sept 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 7 Sept 2026

    Answer published

    In January 2026, the National Institute for Health and Care Research (NIHR) announced increased investment of over £25 million in the NIHR Brain Tumour Research Consortium. This includes an initial investment of £13.7 million announced in December 2025, a...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

No later same-department questions indexed.

This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.